Advisory Board and Editors HIV

Zandrea Ambrose

Assistant Professor in the Division of Infectious Diseases, Department of Medicine and Graduate Program in Molecular Virology and Microbiology, University of Pittsburgh School of Medicine. Co-Director of the Imaging Core of the Pittsburgh Center for HIV Protein Interactions.

Stefan D Baral

Stefan Baral is a physician epidemiologist and an Associate Professor in the Department of Epidemiology at the Johns Hopkins School of Public Health (JHSPH). Stefan has led epidemiological studies among key populations including men who have sex with men and sex workers in Southern, Eastern, and Western African countries as well as in Central and Southeastern Asia. Stefan acts as the Director of the Key Populations Program for the Center for Public Health and Human Rights at the JHSPH.

Keith A Crandall

Founding Director of the Computational Biology Institute at George Washington University. Past Chair of the Department of Biology at Brigham Young University. PhD in Biology and Biomedical Sciences from Washington University in St. Louis.

Barbara Ensoli

Director of the National AIDS Center, Istituto Superiore di Sanità, Rome, Italy. Co-Vice President and Member of the Presidential Committee of the AIDS National Commission, Ministry of Health. Member of the European Molecular Biology Organisation (EMBO).

Shou-Jiang (SJ) Gao

Professor of Molecular Microbiology and immunology at Keck School of Medicine, University of Southern California.

Delia Goletti

Delia Goletti MD, PhD, Infectious Diseases specialist. In 1992 she joined the Laboratory of Immunoregulation at the National Institutes of Health (chief Dr Fauci) working on HIV pathogenesis. In 1999 she joined the National Institute for Infectious Diseases in Rome. She has clinical duties on the tuberculosis (TB) clinic and responsibility of the Translational Research Unit where she works on TB pathogenesis, TB immunodiagnostic tests and impact of Heminths infection on HIV and TB disease.

Bill Hooker

PhD = cloning and characterizing potential vaccine antigens from schistosomes; first postdoc = fine details of HIV replication (with David Harrich); second postdoc = best ignored; third postdoc = role of Max network, especially Mnt, in cancer and development (with Peter Hurlin). Now I make HIV and other diagnostic devices in a small biotech company.

Alessandra Lo Presti

Expert in molecular epidemiology and phylogeny of infectious disease. Principal investigator of the Project “Cross Sectional study to evaluate the interactions between gut microflora and immune system at the cross-road of the pathogenesis of Inflammatory Bowel Diseases and Irritable Bowel Sydrome.”

George N. Pavlakis

MD, U. of Athens, Greece
PhD, Syracuse U, NY
Chief of the Human Retrovirus Section of the National Cancer Institute, USA
Interests: HIV pathogenesis, Molecular Biology, gene regulation, Biotechnology, protein engineering, cytokines, Immunotherapy, Vaccines, Nucleic acid vaccines, gene therapy

Steffanie A. Strathdee

Associate Dean of Global Health Sciences, Harold Simon Professor and Chief of the Division of Global Public Health in the Department of Medicine at the University of California San Diego School of Medicine. She is an infectious disease epidemiologist with expertise in HIV and STD prevention interventions. In 2009, she and her team were awarded the Leadership Award in International Collaboration from the National Institute on Drug Abuse (NIDA). She also holds a MERIT award from NIDA.

Keisuke Yusa

Chief, Laboratory for Virus Safety, Division of Biological Chemistry & Biologicals, National Institute of Health Sciences